Co-Diagnostics Submits FDA 510(k) Application for Infectious Disease Diagnosis Platform
Co-Diagnostics completed its first FDA application for 510(k) clearance for the Co-Dx PCR Pro instrument and the Co-Dx PCR COVID-19 Test.
Read MorePosted by Andy Lundin | Jun 14, 2024 | Infectious Diseases |
Co-Diagnostics completed its first FDA application for 510(k) clearance for the Co-Dx PCR Pro instrument and the Co-Dx PCR COVID-19 Test.
Read MorePosted by Andy Lundin | Jun 13, 2024 | Covid 19 |
Watmind USA received FDA Emergency Use Authorization for its rapid OCT SpeedySwab Covid + FLU A&B Self-Test.
Read MorePosted by Andy Lundin | Jun 12, 2024 | Diagnostic Technologies, Podcasts |
In this episode of Clinical Lab Chat, we presented the CEO of Senzo a challenge—is it possible to create a “perfect” diagnostic test?
Read MorePosted by Andy Lundin | Jun 12, 2024 | Covid 19 |
A new study found that at-home antibody tests can effectively detect inadequate COVID immunity, aiding decisions about booster vaccinations.
Read MorePosted by Andy Lundin | Jun 10, 2024 | Flu & Respiratory Infections |
Roche’s cobas liat COVID, Influenza A/B & RSV test, is a rapid RT-PCR assay that detects multiple respiratory viruses from a single sample.
Read More